Concord Drugs Ltd

Concord Drugs Ltd. Proposes Share Capital Increase 📈

- Authorized Share Capital increase: ₹11 Cr → ₹15.5 Cr

- Equity Shares to rise from 1.1 Cr to 1.55 Cr (face value: ₹10/share)

- Amendment to Capital Clause (Clause V) of Memorandum of Association required

- Board approved the change on July 3, 2025

- Shareholder approval via Ordinary Resolution at EGM pending